The Trump administration is preparing to impose new tariffs on drugmakers that have not struck deals with the president to lower their U.S. drug prices.

Nel mirino della Casa Bianca le Big Pharma che non hanno rispettato l’impegno a costruire un nuovo stabilimento negli Stati Uniti

The Trump administration is preparing to impose new tariffs on drugmakers that have not struck deals with the president to lower their U.S. drug prices.

Drug companies that commit to moving production to the U.S. will face a 20% tariff and no tariff if they also agree to lower prices.

The order does not affect generic medicines, the most commonly used in the US.

New tax will hit branded drugs and active ingredients while exempting generics for at least one year

US president has said that he will use tariffs to bring down costly medical drugs, but the impact remains uncertain.

Trump announces a 100% tariff on certain patented drugs, aiming to boost U.S. pharmaceutical production and negotiate lower prices.

Drug price watchdogs worry President Donald Trump's plan to assess 100% tariffs on drug imports could lighten patients pocketbooks.